ArticleHIV medicine2020

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation.

O T Stirrup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.